Announcements Trials

Browse Landscape

Status

Recruiting 88 Active not recruiting 39 Completed 27 Not yet recruiting 17 Terminated 7 Suspended 4 Enrolling by invitation 3 Withdrawn 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Osteosarcoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Granuloma, Plasma Cell 1 Glioma 1 Carcinoma, Renal Cell 1 Adenocarcinoma of Lung 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Glioma × 90 days × Clear all

NCT06743100 2026-05-29

18F-Floretyrosine Expanded Access Program

Telix Pharmaceuticals (Innovations) Pty Limited

No longer available

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡